Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV-1 Screening Tests Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ELISA
1.2.3 Rapid Tests
1.2.4 Home Access Dried Blood Spot
1.3 Market by Application
1.3.1 Global HIV-1 Screening Tests Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV-1 Screening Tests Market Perspective (2019-2030)
2.2 HIV-1 Screening Tests Growth Trends by Region
2.2.1 Global HIV-1 Screening Tests Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HIV-1 Screening Tests Historic Market Size by Region (2019-2024)
2.2.3 HIV-1 Screening Tests Forecasted Market Size by Region (2025-2030)
2.3 HIV-1 Screening Tests Market Dynamics
2.3.1 HIV-1 Screening Tests Industry Trends
2.3.2 HIV-1 Screening Tests Market Drivers
2.3.3 HIV-1 Screening Tests Market Challenges
2.3.4 HIV-1 Screening Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV-1 Screening Tests Players by Revenue
3.1.1 Global Top HIV-1 Screening Tests Players by Revenue (2019-2024)
3.1.2 Global HIV-1 Screening Tests Revenue Market Share by Players (2019-2024)
3.2 Global HIV-1 Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV-1 Screening Tests Revenue
3.4 Global HIV-1 Screening Tests Market Concentration Ratio
3.4.1 Global HIV-1 Screening Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV-1 Screening Tests Revenue in 2023
3.5 HIV-1 Screening Tests Key Players Head office and Area Served
3.6 Key Players HIV-1 Screening Tests Product Solution and Service
3.7 Date of Enter into HIV-1 Screening Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV-1 Screening Tests Breakdown Data by Type
4.1 Global HIV-1 Screening Tests Historic Market Size by Type (2019-2024)
4.2 Global HIV-1 Screening Tests Forecasted Market Size by Type (2025-2030)
5 HIV-1 Screening Tests Breakdown Data by Application
5.1 Global HIV-1 Screening Tests Historic Market Size by Application (2019-2024)
5.2 Global HIV-1 Screening Tests Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HIV-1 Screening Tests Market Size (2019-2030)
6.2 North America HIV-1 Screening Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HIV-1 Screening Tests Market Size by Country (2019-2024)
6.4 North America HIV-1 Screening Tests Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV-1 Screening Tests Market Size (2019-2030)
7.2 Europe HIV-1 Screening Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HIV-1 Screening Tests Market Size by Country (2019-2024)
7.4 Europe HIV-1 Screening Tests Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV-1 Screening Tests Market Size (2019-2030)
8.2 Asia-Pacific HIV-1 Screening Tests Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HIV-1 Screening Tests Market Size by Region (2019-2024)
8.4 Asia-Pacific HIV-1 Screening Tests Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV-1 Screening Tests Market Size (2019-2030)
9.2 Latin America HIV-1 Screening Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HIV-1 Screening Tests Market Size by Country (2019-2024)
9.4 Latin America HIV-1 Screening Tests Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV-1 Screening Tests Market Size (2019-2030)
10.2 Middle East & Africa HIV-1 Screening Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HIV-1 Screening Tests Market Size by Country (2019-2024)
10.4 Middle East & Africa HIV-1 Screening Tests Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens AG (Germany)
11.1.1 Siemens AG (Germany) Company Detail
11.1.2 Siemens AG (Germany) Business Overview
11.1.3 Siemens AG (Germany) HIV-1 Screening Tests Introduction
11.1.4 Siemens AG (Germany) Revenue in HIV-1 Screening Tests Business (2019-2024)
11.1.5 Siemens AG (Germany) Recent Development
11.2 Roche Diagnostics (Switzerland)
11.2.1 Roche Diagnostics (Switzerland) Company Detail
11.2.2 Roche Diagnostics (Switzerland) Business Overview
11.2.3 Roche Diagnostics (Switzerland) HIV-1 Screening Tests Introduction
11.2.4 Roche Diagnostics (Switzerland) Revenue in HIV-1 Screening Tests Business (2019-2024)
11.2.5 Roche Diagnostics (Switzerland) Recent Development
11.3 Abbott Laboratories (U.S)
11.3.1 Abbott Laboratories (U.S) Company Detail
11.3.2 Abbott Laboratories (U.S) Business Overview
11.3.3 Abbott Laboratories (U.S) HIV-1 Screening Tests Introduction
11.3.4 Abbott Laboratories (U.S) Revenue in HIV-1 Screening Tests Business (2019-2024)
11.3.5 Abbott Laboratories (U.S) Recent Development
11.4 Danaher Corporation (US)
11.4.1 Danaher Corporation (US) Company Detail
11.4.2 Danaher Corporation (US) Business Overview
11.4.3 Danaher Corporation (US) HIV-1 Screening Tests Introduction
11.4.4 Danaher Corporation (US) Revenue in HIV-1 Screening Tests Business (2019-2024)
11.4.5 Danaher Corporation (US) Recent Development
11.5 Thermo-Fisher Scientific Inc (US)
11.5.1 Thermo-Fisher Scientific Inc (US) Company Detail
11.5.2 Thermo-Fisher Scientific Inc (US) Business Overview
11.5.3 Thermo-Fisher Scientific Inc (US) HIV-1 Screening Tests Introduction
11.5.4 Thermo-Fisher Scientific Inc (US) Revenue in HIV-1 Screening Tests Business (2019-2024)
11.5.5 Thermo-Fisher Scientific Inc (US) Recent Development
11.6 Merck KGaA (Germany)
11.6.1 Merck KGaA (Germany) Company Detail
11.6.2 Merck KGaA (Germany) Business Overview
11.6.3 Merck KGaA (Germany) HIV-1 Screening Tests Introduction
11.6.4 Merck KGaA (Germany) Revenue in HIV-1 Screening Tests Business (2019-2024)
11.6.5 Merck KGaA (Germany) Recent Development
11.7 Becton, Dickinson and Company (US)
11.7.1 Becton, Dickinson and Company (US) Company Detail
11.7.2 Becton, Dickinson and Company (US) Business Overview
11.7.3 Becton, Dickinson and Company (US) HIV-1 Screening Tests Introduction
11.7.4 Becton, Dickinson and Company (US) Revenue in HIV-1 Screening Tests Business (2019-2024)
11.7.5 Becton, Dickinson and Company (US) Recent Development
11.8 Hologic, Inc (US)
11.8.1 Hologic, Inc (US) Company Detail
11.8.2 Hologic, Inc (US) Business Overview
11.8.3 Hologic, Inc (US) HIV-1 Screening Tests Introduction
11.8.4 Hologic, Inc (US) Revenue in HIV-1 Screening Tests Business (2019-2024)
11.8.5 Hologic, Inc (US) Recent Development
11.9 Alere Inc (US)
11.9.1 Alere Inc (US) Company Detail
11.9.2 Alere Inc (US) Business Overview
11.9.3 Alere Inc (US) HIV-1 Screening Tests Introduction
11.9.4 Alere Inc (US) Revenue in HIV-1 Screening Tests Business (2019-2024)
11.9.5 Alere Inc (US) Recent Development
11.10 Bio-Rad Laboratories (US)
11.10.1 Bio-Rad Laboratories (US) Company Detail
11.10.2 Bio-Rad Laboratories (US) Business Overview
11.10.3 Bio-Rad Laboratories (US) HIV-1 Screening Tests Introduction
11.10.4 Bio-Rad Laboratories (US) Revenue in HIV-1 Screening Tests Business (2019-2024)
11.10.5 Bio-Rad Laboratories (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details